IAPP boosts islet macrophage IL-1 in type 2 diabetes

被引：30
|
作者：
Mandrup-Poulsen, Thomas [1 ,2 ,3 ]
机构：
[1] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark
[2] Hagedorn Res Inst, Gentofte, Denmark
[3] Karolinska Inst, Dept Med & Surg, Stockholm, Sweden
来源：
NATURE IMMUNOLOGY | 2010年 / 11卷 / 10期
关键词：
OXIDATIVE STRESS; INTERLEUKIN-1; ACTIVATION; MELLITUS; PROTEIN;
D O I：
10.1038/ni1010-881
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
IAPP, a hormone secreted together with insulin and deposited in pancreatic islets in type 2 diabetes, can induce macrophage processing of interleukin 1 linked to beta-cell destruction in type 2 diabetes.
引用
收藏
页码：881 / 883
页数：4
相关论文
共 50 条
  • [41] Adenosine through the A2A adenosine receptor increases IL-1β in the brain contributing to anxiety
    Chiu, Gabriel S.
    Darmody, Patrick T.
    Walsh, John P.
    Moon, Morgan L.
    Kwakwa, Kristin A.
    Bray, Julie K.
    McCusker, Robert H.
    Freund, Gregory G.
    BRAIN BEHAVIOR AND IMMUNITY, 2014, 41 : 218 - 231
  • [42] Islet autoimmunity in phenotypic type 2 diabetes patients
    Brooks-Worrell, B.
    Narla, R.
    Palmer, J. P.
    DIABETES OBESITY & METABOLISM, 2013, 15 : 137 - 140
  • [43] Mechanisms of islet amyloidosis toxicity in type 2 diabetes
    Abedini, Andisheh
    Schmidt, Ann Marie
    FEBS LETTERS, 2013, 587 (08) : 1119 - 1127
  • [44] IL-1 mediates amyloid-associated islet dysfunction and inflammation in human islet amyloid polypeptide transgenic mice
    Westwell-Roper, Clara Y.
    Chehroudi, Cyrus A.
    Denroche, Heather C.
    Courtade, Jaques A.
    Ehses, Jan A.
    Verchere, C. Bruce
    DIABETOLOGIA, 2015, 58 (03) : 575 - 585
  • [45] IL-1 RN 2/2 genotype and simultaneous carriage of genotypes IL-1 RN 2/2 and IL-1β-511 T/T associated with oesophagitis in Helicobacter pylori-negative patients
    Koivurova, OP
    Karhukorpi, JMJ
    Joensuu, ET
    Koistinen, PO
    Valtonen, JM
    Karttunen, TJ
    Niemelä, SE
    Karttunen, RA
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2003, 38 (12) : 1217 - 1222
  • [46] The analysis of IL-1 beta and its naturally occurring inhibitors in multiple sclerosis: The elevation of IL-1 receptor antagonist and IL-1 receptor type II after steroid therapy
    Dujmovic, Irena
    Mangano, Katia
    Pekmezovic, Tatjana
    Quattrocchi, Cinzia
    Mesaros, Sarlota
    Stojsavljevic, Nebojsa
    Nicoletti, Ferdinando
    Drulovic, Jelena
    JOURNAL OF NEUROIMMUNOLOGY, 2009, 207 (1-2) : 101 - 106
  • [47] Limitations of IL-2 and Rapamycin in Immunotherapy of Type 1 Diabetes
    Baeyens, Audrey
    Perol, Louis
    Fourcade, Gwladys
    Cagnard, Nicolas
    Carpentier, Wassila
    Woytschak, Janine
    Boyman, Onur
    Hartemann, Agnes
    Piaggio, Eliane
    DIABETES, 2013, 62 (09) : 3120 - 3131
  • [48] Astrocytic ceruloplasmin expression, which is induced by IL-1β and by traumatic brain injury, increases in the absence of the IL-1 type 1 receptor
    Kuhlow, CJ
    Krady, JK
    Basu, A
    Levison, SW
    GLIA, 2003, 44 (01) : 76 - 84
  • [49] IL-2 therapy in type 1 diabetes: "Trials" and tribulations
    Long, S. Alice
    Buckner, Jane H.
    Greenbaum, Carla J.
    CLINICAL IMMUNOLOGY, 2013, 149 (03) : 324 - 331
  • [50] The Expression of GPR109A, NF-kB and IL-1β in Peripheral Blood Leukocytes from Patients with Type 2 Diabetes
    Liu, Fengxiu
    Fu, Yucai
    Wei, Chiju
    Chen, Yongru
    Ma, Shuhua
    Xu, Wencan
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2014, 44 (04) : 443 - 448
12345